文献速递头颈外科

治疗前FDG-PET/CT热点与头颈鳞癌化放疗后局部复发优先部位的关联

Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
PubMed 文献 · Head Neck · 2017-03-06

纳入72例局部晚期头颈鳞癌患者,于初始分期和治疗后随访行FDG-PET/CT,比较原发灶不同SUVmax阈值亚体积与复发灶亚体积的重叠度。19例(26%)出现局部复发;40% SUVmax阈值下复发者初始代谢肿瘤体积和总病灶糖酵解显著高于控制者,但初始与复发亚体积重叠指数仅中度一致,作者认为可能与配准欠佳有关。

要点

  • 72例局部晚期头颈鳞癌,19例(26%)局部复发。
  • 40% SUVmax阈值下,复发者初始代谢肿瘤体积显著高于控制者。
  • 初始与复发亚体积重叠指数仅中度一致(0.52至0.43)。

核心结论

  • 初始肿瘤与复发亚体积之间未发现高重叠指数,作者认为可能与配准欠佳有关。
  • 代谢肿瘤体积和总病灶糖酵解与头颈鳞癌患者的无复发生存独立相关。
  • 作者认为需要更大规模的前瞻性研究,采用同一放疗体位FDG-PET/CT和经过验证的弹性配准方法。

研究设计与样本

  • 连续纳入72例接受放疗±化疗的局部晚期头颈鳞癌患者。
  • 所有患者于初始分期(PETA)和系统随访(PETR)行FDG-PET/CT。
  • FDG-PET/CT以刚性方法配准至初始CT扫描。

主要发现

  • 19例患者(26%)出现局部复发。
  • 使用40% SUVmax阈值,复发者初始代谢肿瘤体积显著高于控制者(10.4±8.6 vs 5.1±4.9 cc;p=.002)。
  • 使用40% SUVmax阈值,复发者总病灶糖酵解显著高于控制者(117.9±88.6 vs 60.6±80.4;p=.013)。
  • PETA上A30、A40、A50亚体积与PETR上复发灶R40、R70全代谢体积的重叠指数呈中度一致(0.52至0.43)。

关键数值与推荐

  • 原发灶亚体积阈值AX:X=30%、40%、50%、60%、70%、80%、90% SUVmax。
  • 复发灶亚体积阈值RX:X=40%和70% SUVmax。

局限性

  • 作者认为初始肿瘤与复发亚体积重叠指数不高可能与配准欠佳有关。
  • 作者指出需要更大规模的前瞻性研究,采用同一放疗体位FDG-PET/CT和经过验证的弹性配准方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The potential benefits of 18 F-fluoro-2-deoxy-D-glucose-positron emission tomography/CT (FDG-PET/CT) imaging for radiotherapy (RT) treatment planning of head and neck squamous cell carcinoma (HNSCC) are increasingly being recognized. It has been suggested that intratumoral subvolumes with high FDG avidity ("hotspots") are potential targets for selected dose escalation. The purposes of this study were to demonstrate that pre-RT FDG-PET/CT can identify intratumoral sites at increased risk of local relapse after RT and to determine an optimal threshold to delineate smaller RT target volumes that would facilitate RT dose escalation without impaired tolerance. METHODS: Seventy-two consecutive patients with locally advanced HNSCC treated by RT ± chemotherapy were included in this study. All patients underwent FDG-PET/CT at initial staging (PETA ) and during systematic follow-up (PETR ). FDG-PET/CT was coregistered on the initial CT scan with a rigid method. Various subvolumes (AX ; × = 30%, 40%, 50%, 60%, 70%, 80%, and 90% standardized uptake value maximum [SUVmax] thresholds) within the primary tumor and in the subsequent local relapse (RX ; × = 40% and 70% SUVmax thresholds) were compared together (Dice, Jaccard, overlap fraction, common volume/baseline volume, and common volume/recurrent volume). RESULTS: Nineteen patients (26%) had local relapses. Using a 40% SUVmax threshold, the initial metabolic tumor volume was significantly higher in patients with local relapses than in controlled patients (10.4 ± 8.6 vs 5.1 ± 4.9 cc; p = .002) as well as total lesion glycolysis (117.9 ± 88.6 vs 60.6 ± 80.4; p = .013). For both methods, the overlap index among A30 , A40 , and A50 subvolumes on PETA and the whole metabolic volume of recurrence R40 and R70 on PETR showed a moderate agreement (0.52 to 0.43). CONCLUSION: Our study does not find high overlap index values between the initial tumor and recurrence subvolumes, probably because of a suboptimal coregistration. Our results also confirm that metabolic tumor volume and total lesion glycolysis are independently correlated with recurrence-free survival in patients with HNSCC. Further larger prospective studies with FDG-PET/CT performed in the same RT position and with a validated elastic registration method are needed. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1155-1165, 2017.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Chaput A, Calais J, Robin P, et al. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma. Head Neck. 2017. PMID: 28263422. doi:10.1002/hed.24738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。